The human heart does not regenerate. Instead 
Introduction
Ischaemic heart disease is among the leading causes of death worldwide and thus cardiac regeneration has caught an everincreasing interest among scientists [1] . The ability of the heart to regenerate has been studied since the mid-nineteenth century and the consistent conclusion has been that the heart has little or no regenerative capacity [2, 3] 
. Recently, however, an increasing number of studies have reported induction of cardiomyocyte proliferation and cardiac regeneration. Nevertheless, it is still disputed to what extent cardiomyocyte proliferation can be induced and whether induction of proliferation can be utilized therapeutically.
Mammalian cardiomyocytes in vivo lose their ability to proliferate and exit the cell cycle during the first weeks after birth [3, 4] . Therefore, the adult mammalian heart is considered incapable of regeneration after ischaemic or other forms of injury. Natural compensatory processes of the injured heart are limited to hypertrophy of the remaining cardiomyocytes and replacement of necrotic regions with fibrotic scar tissue. Cardiac scarring and loss of contractile tissue can cause arrhythmias, dilation, heart failure and other complications, contributing significantly to morbidity and mortality [1, 5] . Recent progress in conventional treatment has reduced early mortality from myocardial infarction. However, these treatment regimens fail to correct the primary cause of impaired heart function: the loss of cardiomyocytes. Therefore, two strategies have been employed in recent years: cell replacement through cell therapy and induction of endogenous cardiomyocyte proliferation.
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Multiple cell types have been tested for repopulation of the injured myocardium to improve heart function. At first, it had been demonstrated that transplanted foetal and neonatal cardiomyocytes could functionally integrate and enhance recipient cardiac function [6] . Therefore [7] . On the other hand, clinical studies in patients with chronic myocardial disease have consistently reported modest improvements in ventricular function and clinical status [8] .
A plethora of different types of stem cells have been tested. Several studies have reported improved cardiac function after transplantation of bone marrow-derived stem cells, i.e. mesenchymal stem cells (MSC)
and haematopoeietic stem cells (HSC) , in animal models of myocardial injury [9, 10] as well as in clinical trials [11, 12] . However, the improvement is rather minor and, as recently reported, might be only transient [13, 14] .
Many stem cell types can be forced in vitro to differentiate into cardiomyocytes [15] . However, various experiments using several stem/progenitor cell types indicate that there is little or no differentiation of the engrafted cells into cardiomyocytes in vivo and that their survival rate is low, with the exception of embryonic stem cells [16] [17] [18] . Therefore, the mechanism of stem cell therapy is still controversial. The main current opinion is that stem cells as well as skeletal myoblasts secrete cytokines and/or growth factors that cause the functional improvement by stimulating neovascularization, cardiomyocyte proliferation and/or preventing apoptosis [15, [19] [20] [21] [22] [23] . Recently, it has been reported that the mammalian heart contains resident cardiac stem cells (CSC) . The possibilities of expanding autologous CSCs ex vivo or stimulating the regeneration capacity of these cells in vivo are exciting options for therapeutic regeneration [24] .
Cardiac regeneration through cardiomyocyte proliferation is appealing because mammalian heart growth during foetal development as well as newt heart regeneration is mediated by cardiomyocyte proliferation [3, 23] . The mechanism of cardiac regeneration in zebrafish remains unclear but it appears at least to be partially based on cardiomyocyte proliferation [25] . Cell proliferation is an orderly sequence of events in which cells duplicate their contents and then divide. This cycle of duplication and cell division is known as the cell cycle (Fig. 1) [4, 26] .
In [27] [28] [29] [30] .
The cardiac muscle of amphibians is capable of regenerating up to 50% of the ventricle after mechanical excision. This process involves dedifferentiation of the remaining cardiac muscle cells and proliferation of both cardiomyocytes and connective tissue cells [30] [31] [32] . To increase the proliferative response, the apical portion of the newt ventricle was amputated, minced and placed onto the amputation gap. This procedure was followed by a period of proliferation that peaked at 16 days after amputation [28] . These data suggest that in urodele amphibians most of the mature cardiomyocytes retain the ability to proliferate.
To further understand the process of newt cardiac regeneration, ventricular cardiomyocytes were placed into cell culture. DNA synthetic and mitotic activity in these cultures was studied using 24-hr [35] . Unfortunately, zebrafish cardiomyocyte proliferation has so far not been achieved in vitro. Recent data suggest that stem/progenitor cells might also be involved in this process [36] .
In conclusion, these data strongly suggest that naturally occurring heart regeneration in lower vertebrates is based on cardiomyocyte proliferation.
Features of dividing cardiomyocytes
Shortly after birth, mammalian cardiomyocytes stop proliferating. Continuous heart growth is based on increase in cell size, i.e. hypertrophic growth [37] . This transition is characterized by maturation of the contractile apparatus, a cytoplasmic structure that is thought to preclude cytokinesis [3] . Historically [38, 39] .
In [3] . Interestingly, as they differentiate, foetal beating cardiomyocytes still undergo cytokinesis [40, 41] . In chick the mitotic index even increases from 1.5% at 30 hrs after incubation to a peak of 3.2% by 4 days when myofibrils accumulate [42] [43] [44] . This demonstrates that differentiation and proliferation are compatible in cardiomyocytes.
Naturally occurring proliferation of cardiomyocytes from newt and developing chick, rat and mouse myocardium have been studied with several techniques including high laser confocal microscopy and live cell imaging [3, 31, [40] [41] [42] [43] [44] [45] [46] [41] . Fig. 2) [3] . [40, 44] . This evidence from static pictures has also been observed in live cell imaging studies depicting actively contracting rat cardiomyocytes in a state of division. The authors noted that the myocardial cell, in contrast to non-myocytes, did not round up prior to division [46] .
In 1977, it was concluded, from the observation of mitotic figures in injured adult hearts, that 'a limited percentage' of adult mammalian cardiomyocytes can 'pass through all phases of the mitotic cycle' and that this was associated with the transient disassembly of the contractile apparatus (
Interestingly, dividing cardiomyocytes in vitro and in whole mount preparations retain close contact with their non-dividing neighbours throughout all phases of mitosis. Persistence of desmosome-like structures prevents the mitotic cell from a completely rounding off and from the loss of its association with the neighbouring cells
Taken together, a plethora of characteristic features of dividing cardiomyocytes has been collected over the last decades. These data provide a framework for careful analysis of recent data reporting the induction of proliferation of cardiomyocytes and cardiac regeneration. [3, 54, 55] and for the myocardium of c-myc transgenic mice [56] .
Cell division versus poly-nucleation and endoreduplication
Recently, a study concluded from Ki-67 stainings and mitotic figures that human cardiomyocytes undergo cell division after acute myocardial infarction [49] . However, (Fig. 4) . Similar problems have been described in an editorial questioning the occurrence of cardiac chimerism [61] and in a review on stem cell-based cardiac regeneration [62] . Thus, cardiomyocyte-specific cytoplasmic markers are not suitable to distinguish cardiomyocyte from non-myocyte nuclei [63, 64] . Even a 3D reconstruction of cytoplasmic-stained cardiomyocytes appears to be inconclusive [59, 65] .
To avoid false-positives, markers that stain the cell membrane of cardiomyocytes, such as Caveolin 3, could be used [66, 67] . Non-myocyte but not cardiomyocyte nuclei will be separated from the cardiomyocte cytoplasm by cell membrane (Fig. 4) [64, 70] . This is unusual, as disassembly of the myofibrils has to take place to allow cell division. Another atypical observation has been reported after Cyclin A2 overexpression: cardiomyocytes detach and round up during mitosis [71] . Finally, to define cardiomyocyte cytokinesis it is important to observe the precise localization of cytokinetic markers and not simply evaluate the generalized expression of these markers. Aurora B, for example, associates with centromeric heterochromatin early in mitosis, transfers to the central spindle and finally localizes to the contractile ring and midbody [72] [59] . [74] . Furthermore, it has been shown that cells in the end stage of cytokinesis can fail to undergo cell division and reverse their cytoplasmic constriction resulting in poly-nucleated cells [75] . A molecular marker that has been described to indicate whether a cytokinetic cardiomyocyte will undergo binucleation rather than cell division is Anillin [73] . Anillin was originally identified as an actin-binding protein. It localizes to the cleavage furrow, binds septins, associates with mysosin II, and is required for cytokinesis [76] . [78] .
. However, in cardiomyocytes it can localize at the midbody during proliferation as well as binucleation. Furthermore, it has been suggested that contraction of the contractile ring and cleavage furrow ingression is disturbed during binucleation [73]. In a recent study, several examples of Aurora B-positive cardiomyocytes were presented. Whereas some of the examples indicate cell division others are rather indicative for binucleation as the cardiomyocytes undergo a one-sided furrow ingression
Although it is impossible to confer from BrdU-labelling, H3P-or Aurora B staining that cells proliferate the combination of these results can indicate problems in cell cycle progression. DNA synthesis is detected by incorporation of BrdU during S phase. This method allows detecting all cells that have entered S phase during the labelling period. In contrast, mitosis can only be detected at the moment it occurs, usually utilizing antibodies against H3P. In addition, mitosis and cytokinesis are the shortest phases of the cell cycle. Therefore, even fast proliferating cells like foetal cardiomyocytes in vivo or HeLa cells show a relatively low percentage of H3P-positive cells (3.7% or 7%, respectively) [67]. Thus, a fast proliferating cell population will have a mitotic/cytokinetic index of approximately 7% and a BrdU-labelling index of 100%, when labelled for 24 hrs, giving a ratio of 14.29. If there are problems in executing or in progressing through mitosis/cytokinesis this ratio will decrease. In a study describing the effect of Periostin, the authors reported a BrdU-labelling index of 1.1% (3 days BrdU-labelling) and a cytokinesis index of 0.5% resulting in a surprisingly low ratio of 2.2 [59]. Another study describing the effect of GSK-3 inhibitor Bio reports for adult cardiomyocytes a higher mitotic index than for neonatal cardiomyocytes (2.41% versus 2.25%) although the BrdU-labelling index was lower (13.1% versus 47.2%) [60]. There are several possible explanations for those data: (1) The cells accumulate during cytokinesis due to a cell division defect or (2) the cells have been induced to enter the cell cycle and almost synchronously progressed through the cell cycle into cytokinesis.
Very few studies have combined detection of DNA synthesis, mitosis and cytokinesis and added cell count assays to their analyses. This is important as detection of proteins involved in cytokinesis does not unequivocally prove proliferation. For example, it has been demonstrated that septins, another protein family involved in contractile ring formation, are re-expressed during pathological hypertrophy
The first attempts to induce neonatal cardiomyocyte proliferation employed viral proteins two decades ago. Expression of T antigen was associated with mitotic figures and a 3-fold increase in the number of myocardial cells 72 hrs after infection. Within a week, the density of myocardial cells reached confluence. It is noteworthy that in this study not all mitotic cells underwent cytokinesis.
The mitotic index was more than 20-fold increased (4.3% versus 0.2%). However, the number of poly-nucleated cells also increased by almost 4-fold (8.6% versus 2.3%) [77]. Busk and co-workers used similar approaches to demonstrate that Cyclin D2 overexpression results in an increase in cell number of neonatal cardiomyocytes (1.8-fold) and of 21 days old cardiomyocytes in the presence of serum (2-fold) at 6 days after infection
Recently [82, 83] . Finally, the recent finding that an extracellular matrix protein can induce cardiomyocyte proliferation highlights the importance of the microenvironment [59] . Previously, it had already been suggested that extracellular matrix proteins play an important role in peripheral nerve regeneration and cancer development [84, 85] .
Whether cardiac dedifferentiation can be induced in vivo or whether the re-expression of the foetal gene program during hypertrophy or cardiac injury is comparable to the observed cardiac dedifferentiation during natural occurring regeneration remains unclear.
Induction of cardiac regeneration
Studies to date have shown that cyclin D2 [86] , cyclin A2 [63] , FGF5 [87, 88] , VEGF165 [89] , Periostin [59] and FGF1/p38 inhibitor [66] [94] . First, there could be a direct effect of the treatment on the remaining cardiomyocytes after injury, such as protection against irreversible injury [95, 96] , increased compensatory hypertrophy [87] , or alterations in calcium handling that could improve contractility [97] . Second [106, 107] . Therefore, induction of cardiomyocyte proliferation in the peri-infarct region might just have a transient effect on heart regeneration if the vasculature and other supporting cells are not restored. This might explain why p38 inhibition that has no effect on capillary density causes only a transient effect in improving heart function despite induction of cardiomyocyte proliferation [66] . Insufficient revascularization might also be the reason why overexpression of cmyc [108] [109] [110] and cdk2 [111] [113, 114] .
Recently, it has also been demonstrated that complete cell division can be induced in adult cardiomyocytes [67] . However, in contrast to neonatal cardiomyocytes, this induction is not efficient. The main problem hereby appears to be the transition from mitosis to cytokinesis and its completion.
Taken together, the scientific community has gathered a plethora of data that allows the encouraging conclusion that repopulation of the heart by inducing cardiomyocyte proliferation is a realistic future option for cardiac repair. At the same time, we urge to a critical analysis of data regarding this hot topic to avoid misinterpretations and too fast conclusions.
